Cargando…

Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter

AIMS: To assess the impact of the introduction of direct oral anticoagulants upon the outcomes from elective electrical cardioversion for atrial fibrillation. METHODS: This is a retrospective comparison of delay to elective cardioversion with different anticoagulants. The data was gathered from a la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wall, Christopher, Jankowski, Tania, Naruka, Vinci, Mota, Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317800/ https://www.ncbi.nlm.nih.gov/pubmed/30605492 http://dx.doi.org/10.1371/journal.pone.0210170

Ejemplares similares

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
por: Mentias, Amgad, et al.
Publicado: (2021)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Sternal fracture after elective electrical cardioversion of atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2010)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center
por: Arshad, Samiullah, et al.
Publicado: (2022)

Ibutilide for pharmacological cardioversion of atrial flutter
por: Magnusson, K, et al.
Publicado: (2002)

Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter
por: Malviya, Amit, et al.
Publicado: (2020)

Do we always need anticoagulation before cardioversion of atrial fibrillation in ladies?
por: Görenek, Bülent, et al.
Publicado: (2016)

DC cardioversion of atrial fibrillation and atrial flutter in the emergency department: improving specialist protocols for the generalist
por: Carpenter, Alexander, et al.
Publicado: (2018)

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
por: Wybraniec, Maciej T., et al.
Publicado: (2023)

Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis
por: Shin, Dong Geum, et al.
Publicado: (2015)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
por: Jacobs, Maartje S., et al.
Publicado: (2017)

Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation
por: Son, Nguyen Khac Le, et al.
Publicado: (2020)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021)

SAFETY AND EFFICACY OF SAME-DAY ELECTIVE CORONARY ANGIOGRAPHY AND SYNCHRONIZED CARDIOVERSION IN PATIENTS WITH ATRIAL FIBRILLATION WITH UNINTERRUPTED ANTICOAGULATION
por: Gallen, Rory, et al.
Publicado: (2021)

Prolonged asystole following direct-current cardioversion for atrial flutter.
por: McMullan, R., et al.
Publicado: (2001)

Tolerance of High-Dose Oral Amiodarone for Cardioversion of Atrial Flutter
por: Le, Vincent K., et al.
Publicado: (2022)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Adjunctive Pharmacotherapy for Elective Direct Current Cardioversion in Patients With Atrial Fibrillation
por: Hirt, Liam S., et al.
Publicado: (2012)

Croatia needs a registry of patients undergoing direct current cardioversion for persistent atrial fibrillation/flutter
por: Dubravčić, Mia, et al.
Publicado: (2016)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?
por: Naydenov, Stefan, et al.
Publicado: (2021)

Recurrent Atrial Flutter Requiring Multiple Cardioversions in a Preterm Infant
por: Jaile, Jesus C., et al.
Publicado: (2021)

The RITMIA™ Smartphone App for Automated Detection of Atrial Fibrillation: Accuracy in Consecutive Patients Undergoing Elective Electrical Cardioversion
por: Reverberi, Claudio, et al.
Publicado: (2019)

Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry
por: Papp, Judit, et al.
Publicado: (2017)

Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2010)

Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation
por: Rochlani, Yogita M., et al.
Publicado: (2016)

Early afterdepolarizations and electrical storm after cardioversion for atrial fibrillation
por: Lypourlis, Dimitrios, et al.
Publicado: (2022)

Left Atrial Appendage Thrombosis During Therapy with Rivaroxaban in Elective Cardioversion for Permanent Atrial Fibrillation
por: Serra, Walter, et al.
Publicado: (2015)

Corrigendum to: Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry
Publicado: (2018)

Outcome Analysis in Elective Electrical Cardioversion of Atrial Fibrillation Patients: Development and Validation of a Machine Learning Prognostic Model
por: Nuñez-Garcia, Jean C., et al.
Publicado: (2022)

Real‐life experience with non‐vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation
por: Itäinen‐Strömberg, Saga, et al.
Publicado: (2020)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
por: Forslund, Tomas, et al.
Publicado: (2021)

Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation
por: Lobo, Ronstan, et al.
Publicado: (2022)

Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials
por: Thind, Munveer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h0v979g96dohklkjj7gqp62ht6